-
Aug 25, 2025
At a time when the federal government is reducing funding for biomedical research at the National Institutes of Health—thereby fraying the partnership between government and...
-
May 29, 2025
The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang for the taxpayers’ buck, writes former FDA...
-
May 6, 2025
U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb explains how to stop the shift.
Aug 25, 2025At a time when the federal government is reducing funding for biomedical research at the National Institutes of Health—thereby fraying the partnership between government and...
May 29, 2025The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang for the taxpayers’ buck, writes former FDA...
May 6, 2025U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb explains how to stop the shift.